#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	18360	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2539	893.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1678	1678	C	1199	C	1199	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	30700	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4031	948.1	0	.	n	.	0	T695C	SNP	695	695	T	1382	1382	C	1133	C,T,G,A	1129,2,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	30700	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4031	948.1	0	.	n	.	0	G1337A	SNP	1337	1337	G	2024	2024	A	1247	A,C	1246,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	30700	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4031	948.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2658	2658	C	1000	C,A,T	996,3,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	30700	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4031	948.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2732	2732	A	944	A,C,T,G	939,2,1,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	30700	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4031	948.1	1	SNP	n	C2597T	0	.	.	2597	2597	C	3284	3284	C	1075	C,T,G	1073,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	30700	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4031	948.1	0	HET	.	.	.	C2403T	.	2403	2403	C	3090	3090	C	1116	C,T	885,231	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	2636	folP	855	855	100.0	folP.l15.c4.ctg.1	1997	164.6	1	SNP	p	R229S	1	.	.	685	687	AGC	1223	1225	AGC	281;281;280	A;G;C	281;281;280	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6092	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3837	198.0	1	SNP	p	S91F	1	.	.	271	273	TTC	843	845	TTC	214;217;214	T;T;C	214;217;214	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6092	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3837	198.0	1	SNP	p	G95N	0	.	.	283	285	GGC	855	857	GGC	231;231;231	G;G,C,A;C	231;229,1,1;231	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6092	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3837	198.0	1	SNP	p	D95G	1	.	.	283	285	GGC	855	857	GGC	231;231;231	G;G,C,A;C	231;229,1,1;231	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	2260	mtrR	633	633	100.0	mtrR.l15.c17.ctg.1	1739	162.2	1	SNP	p	G45D	0	.	.	133	135	GGC	681	683	GGC	271;273;273	G;G;C	271;273;273	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1242	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c17.ctg.1	1432	108.3	0	.	n	.	0	A197.	DEL	197	197	A	773	773	A	246	A	246	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5930	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3359	220.3	1	SNP	p	D86N	0	.	.	256	258	GAC	786	788	GAC	276;273;276	G;A;C	276;273;276	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5930	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3359	220.3	1	SNP	p	R87I	0	.	.	259	261	CGT	789	791	CGT	281;282;282	C;G,A;T	281;281,1;282	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5930	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3359	220.3	1	SNP	p	R87W	0	.	.	259	261	CGT	789	791	CGT	281;282;282	C;G,A;T	281;281,1;282	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5930	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3359	220.3	1	SNP	p	S87R	1	.	.	259	261	CGT	789	791	CGT	281;282;282	C;G,A;T	281;281,1;282	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5930	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3359	220.3	1	SNP	p	S88P	0	.	.	262	264	TCC	792	794	TCC	284;283;288	T;C;C	284;283;288	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4890	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3215	189.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1901	1903	GGC	265;261;262	G,C,A;G,T;C	263,1,1;260,1;262	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	4836	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2841	212.3	1	SNP	p	A311V	0	.	.	931	933	GCA	1463	1465	GCA	304;305;301	G,A;C,A;A,C	303,1;304,1;300,1	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4836	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2841	212.3	1	SNP	p	I312M	0	.	.	934	936	ATC	1466	1468	ATC	299;299;299	A;T;C	299;299;299	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4836	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2841	212.3	1	SNP	p	V316P	0	.	.	946	948	GTG	1478	1480	GTG	277;279;285	G;T;G	277;279;284	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4836	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2841	212.3	1	SNP	p	V316T	0	.	.	946	948	GTG	1478	1480	GTG	277;279;285	G;T;G	277;279;284	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4836	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2841	212.3	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1982	1984	ACC	266;264;263	A;C;C,A	266;264;262,1	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4836	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2841	212.3	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2036	2038	GCG	250;248;245	G;C,G;G	250;247,1;245	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4836	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2841	212.3	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2036	2038	GCG	250;248;245	G;C,G;G	250;247,1;245	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4836	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2841	212.3	1	SNP	p	G543S	1	.	.	1627	1629	AGC	2159	2161	AGC	262;263;264	A;G;C,T	262;263;263,1	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4836	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2841	212.3	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2168	2170	GGC	260;259;263	G,T;G,T;C	259,1;257,2;263	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4836	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2841	212.3	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2186	2188	CCG	249;247;245	C,T;C,G;G	247,1;245,1;244	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6666	ponA	2397	2397	100.0	ponA.l15.c17.ctg.1	3362	246.7	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1770	1772	CCG	270;267;266	C,A;C,A;G	269,1;266,1;266	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2666	porA	1146	1146	99.91	porA.l15.c4.ctg.1	2187	151.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	754	754	C	204	C	204	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3168	porB1b	1038	1038	96.28	porB1b.l6.c4.ctg.1	1935	203.2	0	.	p	.	0	I45V	NONSYN	133	135	ATT	677	679	GTT	271;271;272	G;T;T,G,A	271;271;270,1,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3168	porB1b	1038	1038	96.28	porB1b.l6.c4.ctg.1	1935	203.2	0	.	p	.	0	N121S	NONSYN	361	363	AAC	905	907	AGC	256;255;254	A,C;G;C,A	255,1;255;253,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3168	porB1b	1038	1038	96.28	porB1b.l6.c4.ctg.1	1935	203.2	0	.	p	.	0	N122K	NONSYN	364	366	AAC	908	910	AAA	254;255;257	A,C;A;A,T	253,1;255;256,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3168	porB1b	1038	1038	96.28	porB1b.l6.c4.ctg.1	1935	203.2	0	.	p	.	0	F131Y	NONSYN	391	393	TTT	935	937	TAT	261;258;259	T,C;A;T,G,C	260,1;258;256,2,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3168	porB1b	1038	1038	96.28	porB1b.l6.c4.ctg.1	1935	203.2	0	.	p	.	0	N134E	NONSYN	400	402	AAT	944	946	GAG	262;258;259	G;A,C;G	262;257,1;259	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3168	porB1b	1038	1038	96.28	porB1b.l6.c4.ctg.1	1935	203.2	0	.	p	.	0	V135L	NONSYN	403	405	GTG	947	949	CTT	259;261;262	C;T,G;T,G	259;260,1;261,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3168	porB1b	1038	1038	96.28	porB1b.l6.c4.ctg.1	1935	203.2	0	.	p	.	0	G140K	NONSYN	418	420	GGA	962	964	AAA	267;271;274	A,C;A;A	266,1;271;274	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3168	porB1b	1038	1038	96.28	porB1b.l6.c4.ctg.1	1935	203.2	0	.	p	.	0	Q143E	NONSYN	427	429	CAA	971	973	GAA	274;276;277	G,T;A,C;A,C	273,1;274,2;276,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3168	porB1b	1038	1038	96.28	porB1b.l6.c4.ctg.1	1935	203.2	0	.	p	.	0	V151A	NONSYN	451	453	GTA	995	997	GCA	281;278;278	G,A;C;A	280,1;278;278	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3168	porB1b	1038	1038	96.28	porB1b.l6.c4.ctg.1	1935	203.2	0	.	p	.	0	A196V	NONSYN	586	588	GCC	1130	1132	GTC	299;298;296	G;T,G;C	299;297,1;296	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3168	porB1b	1038	1038	96.28	porB1b.l6.c4.ctg.1	1935	203.2	0	.	p	.	0	K207_M208insK	INS	619	619	A	1163	1163	A	298	A,C	297,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3168	porB1b	1038	1038	96.28	porB1b.l6.c4.ctg.1	1935	203.2	0	.	p	.	0	A212S	NONSYN	634	636	GCA	1181	1183	TCA	297;296;297	T,G;C;A	295,2;296;297	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3168	porB1b	1038	1038	96.28	porB1b.l6.c4.ctg.1	1935	203.2	0	.	p	.	0	Y251fs	FSHIFT	751	751	T	1298	1298	T	239	T	239	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	12178	rpoB	4179	4179	99.98	rpoB.l15.c17.ctg.1	5367	283.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1754	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1565	139.8	1	SNP	p	V57M	1	.	.	169	171	ATG	784	786	ATG	308;308;310	A,G;T;G	307,1;308;310	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
